Janus Henderson Group
IOVA icon

Janus Henderson Group’s Iovance Biotherapeutics IOVA Stock Holding History

Janus Henderson Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Buy
141,672
+50,331
+55% +$161K ﹤0.01% 2007
2025
Q4 		$250K Hold
91,341
– – ﹤0.01% 2282
2025
Q3 		$199K Hold
91,341
– – ﹤0.01% 2344
2025
Q2 		$157K Hold
91,341
– – ﹤0.01% 2365
2025
Q1 		$325K Hold
91,341
– – ﹤0.01% 2174
2024
Q4 		$677K Hold
91,341
– – ﹤0.01% 1885
2024
Q3 		$857K Hold
91,341
– – ﹤0.01% 1752
2024
Q2 		$731K Sell
91,341
-1,131
-1% -$12.1K ﹤0.01% 1790
2024
Q1 		$1.37M Sell
92,472
-15
-0% -$175 ﹤0.01% 1475
2023
Q4 		$751K Sell
92,487
-50
-0.1% -$262 ﹤0.01% 1790
2023
Q3 		$422K Buy
92,537
+88
+0.1% +$575 ﹤0.01% 2021
2023
Q2 		$650K Buy
92,449
+39,821
+76% +$285K ﹤0.01% 1841
2023
Q1 		$321K Buy
52,628
+28,584
+119% +$197K ﹤0.01% 2250
2022
Q4 		$154K Sell
24,044
-24,046
-50% -$188K ﹤0.01% 2252
2022
Q3 		$462K Buy
48,090
+24,021
+100% +$277K ﹤0.01% 1994
2022
Q2 		$265K Buy
24,069
+68
+0.3% +$891 ﹤0.01% 2154
2022
Q1 		$399K Buy
24,001
+16
+0.1% +$247 ﹤0.01% 2036
2021
Q4 		$458K Buy
+23,985
New +$528K ﹤0.01% 1944
2021
Q2 		– Sell
-78,211
Closed -$2.48M – 1638
2021
Q1 		$2.48M Buy
78,211
+60,207
+334% +$2.5M ﹤0.01% 1144
2020
Q4 		$834K Buy
+18,004
New +$715K ﹤0.01% 1219

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Janus Henderson Group's IOVA Position: Q1 2026 in Review

Janus Henderson Group increased its Iovance Biotherapeutics (IOVA) stake by 55% in Q1 2026, buying an estimated $161K and bringing the position to 141,672 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Janus Henderson Group first reported a position in IOVA in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.48M in Q1 2021. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Janus Henderson Group held 141,672 shares of Iovance Biotherapeutics worth $498K as of Q1 2026.
  • Janus Henderson Group bought 50,331 Iovance Biotherapeutics shares in Q1 2026, an estimated $161K.
  • Iovance Biotherapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2007 holding.
  • Janus Henderson Group first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 20 quarters since.
  • Janus Henderson Group's Iovance Biotherapeutics position peaked at $2.48M in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.